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Abstract
Polymer-based electrodes for interfacing biological tissues are becoming increasingly sophisticated.
Their many functions place them at the cross-roads of electromaterials, biomaterials, and drug-delivery
systems. For conducting polymers, the mechanism of conductivity requires doping with anionic
molecules such as extracellular matrix molecules, a process that distinguishes them as biomaterials and
provides a means to control interactions at the cellular-electrode interface. However, due to their complex
structure, directly observing the selective binding of target molecules or proteins has so far eluded
researchers. This situation is compounded by the polymer's ability to adopt different electronic states that
alter the polymer-dopant interactions. Here, the ability to resolve sub-molecular binding specificity
between sulfate and carboxyl groups of dopants and heparin binding domains of human plasma
fibronectin is demonstrated. The interaction exploits a form of biological 'charge complementarity' to
enable specificity. When an electrical signal is applied to the polymer, the specific interaction is switched
to a non-specific, high-affinity binding state that can be reversibly controlled using electrochemical
processes. Both the specific and non-specific interactions are integral for controlling protein
conformation and dynamics. These details, which represent the first direct measurement of biomolecular
recognition between a single protein and any type of organic conductor, give new molecular insight into
controlling cellular interactions on these polymer surfaces.
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Polymer based electrodes for interfacing biological tissues are becoming increasingly sophisticated. Their
many functions place them at the cross-roads of electromaterials, biomaterials and drug delivery
systems. For conducting polymers, the mechanism of conductivity requires doping with anionic
molecules such as extracellular matrix molecules, a process that distinguishes them as biomaterials and
provides a means to control interactions at the cellular-electrode interface. However, due to their
complex structure, directly observing the selective binding of target molecules or proteins has so far
eluded researchers - this situation is compounded by the polymer’s ability to adopt different electronic
states that alter the polymer-dopant interactions. Here, we demonstrate the ability to resolve submolecular binding specificity between sulfate and carboxyl groups of dopants and heparin binding
domains of human plasma fibronectin. The interaction exploits a form of biological ‘charge
complementarity’ to enable specificity. When an electrical signal is applied to the polymer, the specific
interaction is switched to a non-specific, high affinity binding state that can be reversibly controlled
using electrochemical processes. Both the specific and non-specific interactions are integral for
controlling protein conformation and dynamics – these details, which represent the first direct
measurement of biomolecular recognition between a single protein and any type of organic conductor,
give new molecular insight into controlling cellular interactions on these polymer surfaces.
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Introduction
Organic conducting polymers (OCP) permit conductive pathways along their conjugated backbone and are
breaking new grounds in applications such as implantable electrodes for neural recording1 or
stimulation 2,3, tissue regenerative medicine 4, 5, biosensing6, 7, and electronic cell culture systems 8. They are
easily applied as coatings on metal electrodes to increase charge storage capacity, lower impedance and
reduce the risk of toxic electrochemical reactions 9. During growth of the polymer, anionic molecules
(dopants), which can be drugs or other biomolecules, are incorporated to counter balance charge
generated on the polymer backbone. Electrochemical reduction of the polymer to induce charge neutrality
initiates the release of dopants; a reversible process that is utilised in drug delivery applications 10,

11

.

Alternatively, large polyelectrolyte dopants such as glycosaminoglycans (GAGs) (e.g. heparin sulfate,
chondroitin sulfate, hyaluronic acid and dextran sulfate) remain entrapped in the polymer and are used to
present

anchorage

sites

for

chemical

functionalization 12

or

bioactive

groups13,14,

enhance

biocompatibility15,,or bioselectivity16, and control cellular interactions at the electrode surface 17.
Selective binding of target molecules by recognition elements (e.g. dopants) of the polymer is critical for
biosensor, immunosensor and bioseparation applications; however non-specific binding remains an
ongoing issue for obtaining unequivocal electrical readouts. Similarly for cell-based applications, controlling
specific protein interactions at the polymer surface is becoming a key strategy. For example, the
electrically-dependent conformation of proteins is thought to underlie the ability to control cell adhesion 18
and migration 19. By looking at the ensemble conformation of fibronectin (FN) protein using fluorescence
techniques, it is proposed that the proteins electrically ‘switch’ between a folded and unfold state to
control the cell interaction 20. However, the molecular details of such protein interactions are not known
and as yet no direct measurement for probing single protein molecule binding or conformation on an
organic conducting polymer, or any type of organic conductor (e.g. carbon nanotube, and graphene),
under electrical control has been demonstrated; understanding the dynamics and physics of single protein
interactions will be a major step forward in this field of organic bioelectronics. For this reason, we
covalently linked FN to an Atomic Force Microscope (AFM) tip and used force measurements to
demonstrate the first direct measurement of specific protein adhesion to an organic conducting polymer,
polypyrrole, doped with the GAGs, chondroitin sulphate (CS), hyaluronic acid (HA) and dextran sulfate (DS),
as a function of an applied voltage. The GAG dopants can make up to 50% of the polymer composition and
not all their anionic groups participate in charge neutralization of the polymer. For example, free sulfonate
and carboxyl groups are anticipated to be involved in surface interactions defined by classical GAG-protein
adhesion and recognition 21, which is important for regulating cellular activities, including cell adhesion,
extracellular matrix modelling and fibrillogenesis22.

Page 4 of 21

Results and Discussion
Characterization of Protein Functionalized Tip
Human plasma fibronectin (FN) was covalently coupled to the AFM tip using a common procedure
involving gluteraldehyde as cross-linking agent (Figure 1A and see materials and methods). Fluorescent
images of AFM tips labelled with primary anti-fibronectin rabbit antibody before (Figure 1B, left image) and
after (Figure 1B, right image) indicated that the functionalization procedure resulted in an FN coating on
the chip, along the cantilever and at the tip end. Force measurements were performed after each
functionalization step to assess the involvement of the introduced functional groups (i.e. -OH, NH3+ and
C=O) and final coupling of the FN on the interaction between the tip and conducting polymer (Figure 1C).
For these initial measurements, only PPy films doped with CS (PPy/CS) were assessed. Plasma treated
silicon nitride tip (SiN3) bearing –OH groups, which are hydrophilic and negatively charged at neutral pH,
showed no adhesion to (PPy/CS). In contrast, 3-EDSPA treated tips terminated with protonated NH3+
groups at neutral pH showed an electrostatic double layer force that is attractive upon approach followed
by direct tip-surface adhesion of 2.0 ± 0.14 pN during retraction of the tip from the polymer surface. This
attractive interaction with the positively charged tip indicates the polymer surface is negatively charged
and further supports the presence of anionic, sulfate groups of the CS. Similarly to the plasma treated tips,
the gluteraldehyde (GAH) functionalized tips bearing reactive carbonyl groups are hydrophilic though
showed a small adhesion of 406 ± 35 pN with the polymer surface. The interaction of the FN functionalized
tip showed longer range interactions, consisting of multiple adhesion peaks, that are characteristic for this
type of protein interaction observed using AFM 23, 24. These initial force measurements were thus useful in
providing general information on the polymer surface chemistry (e.g. surface charge) and, importantly,
confirming the FN interaction with the polymer, which is discussed in further detail below.

AFM Force Spectroscopy of Fibronectin – Organic Conducing Polymer Interactions
Figure 2A shows a schematic of the protein and chemical structures of the FN and polymer, respectively,
and experimental setup that enables AFM force measurements of the FN-polymer/dopant interactions to
be investigated as a function of an applied potential. During the force spectroscopy measurements, the FNfunctionalized probe is brought into contact with the polymer electrode to initiate binding and then FNsurface adhesion forces acting on the probe are detected as it is withdrawn. Several types of FN-polymer
interactions are detected for non-electrically stimulated polymers (Figure 2B), including no adhesion, ‘nonspecific’ FN binding, and desorption (plateau) forces. The most prevalent FN interaction (42% of force
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curves, n = 900) is that related to the extension of the bound protein until final detachment from the
surface (Figure 2B, top and middle force curve), which is schematically shown in Figure 2C to describe the
corresponding interactions in the force curves. The initial part of this interaction is referred to as ‘nonspecific’ adhesion (Figure 2B and C; i) and related to bulk adhesive interactions of the FN functionalized tip
involving inter- and intra-protein interactions and detachment of several proteins from the surface. If a
single FN protein remains tethered between the tip and surface, force-induced unfolding of domains can
occur (27% of force curves, n = 900) (Fig. 2B; peaks prior to and regions ii and iii) (Figure 2C; ii and iii) and is
identified by successive rupture peaks with spacings of 13.1 ± 0.4 nm (mean ± s.e.m., n = 137) and 28.8 ±
0.7 nm (mean ± s.e.m., n = 107) correlated to the length of unfolded intermediates or FNIII domains23, 25, 26,
respectively (Figure 2D). Forces of 147.1 ± 8.6 pN (mean ± s.e.m., pulling-rate 500 nm/sec, n = 198)
required for domain unfolding are also characteristic of single molecule FN interactions. Successive rupture
peaks also occur due to detachment of multiple FN–polymer binding sites wherein the first binding site
detaches (Figure 2B; peak prior to region iv) (Figure 2C iv), followed by extension of the protein (Figure 2B;
iv), until detachment of the second and final binding site (Figure 2B and C; final peak). These binding events
can occur in the absence of domain unfolding (Figure 2B; v) and have peak spacings of 58.9 ± 3.0 nm (mean
± s.e.m., n = 67) (Figure 2D), which are greater than the lengths of unfolded FN domains and therefore
distinguish detachment of the protein from the surface. This peak spacing of 58.9 ± 3.0 nm also suggests
that binding is most probable at sites on the protein separated by this distance or, alternately, the
existence of specific binding sites on the protein. The detachment of the protein can also proceed less
commonly via ‘non-specific’ desorption forces that show a constant force independent of the extension
length, i.e. plateau forces (Figure 2B; vi in bottom curve). Plateau forces are commonly observed for
polyelectrolyte chain desorption from a surface, much like a polymer chain being ‘peeled’ off the surface,
and arise due to dependencies on the dissociation rate of repeating polymer chain-surface contacts
relative to the extension rate 27 and presence of an oppositely charged surface 28.

To elucidate interactions involving detachment (or effective binding) sites of the protein, we focused on
analysing individual force profiles representing the unfolding and/or extension of FN, as described above in
Figure 2B (top and middle curves). More specifically, the analysis involved subtracting the distances of all
peak spacings, including those associated with unfolding and protein–surface detachment, from the
distance at the final peak. This gives what we refer to as the “corrected binding distance” (CBD),
representing the extended length of the FN, tethered between the tip and surface, just prior to undergoing
domain unfolding and/or surface detachment (Figure 2C; far right schematic). The CBD is thus governed by
the distance between the two attachment positions (dashed lines) of the protein to the tip and polymer;
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this being firstly, the covalent attachment of the protein to the probe and secondly, the non-covalent
protein-surface binding site that is either the first of multiple binding sites to detach, as shown in Figure
2C, or the sole (and final point of detachment) when no other binding sites are present.

Probability density functions of the CBD show a primary peak distribution value ranging from 59 - 66 nm
for all polymers, with a secondary peak distribution value ranging from 116 – 119 nm for CS and DS
polymers and possibly PTS and HA (Figure 3A). Minor peak CBD distribution values also appear at 171 nm
and 166 nm for CS and PTS, respectively (Figure 3A). The significance of these CBD distributions is that,
even though FN binding to the tip is generally expected to be random via gluteraldehyde linkages with
nucleophilic amine groups at the N-terminus and on free lysine residues, their observation indicates that
both the tip and polymer must bind to specific sites on the FN. Furthermore, the presence of CBD values at
166-171 nm corresponds to the length of ≈ 160-175 nm for fully stretched plasma FN 29, F 30, 31. To obtain
these values, it would require that the FN be attached to an N-terminus and interact with the polymer via
the opposing N-terminus. This binding configuration, which presumably allows the entirety of the
extended FN molecule to freely interact, is likely to facilitate binding at additional sites separated by the
distance of 58.9 ± 3.0 nm (mean ± s.e.m., n = 67) previously observed in the rupture spacings (Figure 2D).
Repeated sampling of the 3 different peak CBD distribution values within sets of force curves (n = 25) from
individual AFM tip experiments (n = 36) further supports the detection of multiple binding sites along a
single FN molecule instead of multiple interacting FN molecules having 3 different specific binding
configurations and each with an extended length differing by ≈ 60 nm. These observations suggest that FN
preferentially has a fixed attachment to the tip in the vicinity of an N-terminus with binding occurring at
specific sites along its length.

Based on the above observations, we use the known FN structure and dimensions of the FNI, FNII, FNIII
domains based on X-ray crystallography studies32 to construct coordinate map for identifying positions on
the protein involved in binding to the polymer (Figure 3B). The map gives a calculated FN length of 158.8
nm by taking into account the size of each individual domain and absence of variable splicing regions for
plasma FN. The preferred N-terminus binding position of the tip is made the zero reference point in order
to identify the binding locations. The extent of net positive charge of each FN domain 33, which generally
underlies their binding affinity to sulfate sites on GAGs 34, is also specified. When cross-referencing the
peak distribution values of the CBD (black asterix) to their locations on the model, we observe that they
superimpose to well-known Heparin (Hep) binding domains (Figure 3B; black highlighted domains),
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including a particular sequence of the HepII FNIII12-14 near the COOH-terminus, HepIII FNIII4-6 and HepI FNI15.

Interestingly, the compact conformation of FN is stabilized by intermolecular bonds at the positions of

these three domains35 but can be disrupted by interacting surface groups, particularly hydrophilic and
negatively charged surfaces, causing the protein to adopt a more unfolded conformation 36,37. We suggest
that the binding of this particular sequence of Hep domains is presumably facilitated by their close
association and thus collective presentation to the polymer surface during the force spectroscopy
measurements. The main CBD distribution at 59-66 nm indicates most probable binding occurs at the HepII
domain and accordingly this is recognized as the highest affinity GAG binding site due to the presence of
discontinuous positively charged amino acids in FNIII13-14 domains that form a cationic cradle 38. Standard
deviations of the CBD distributions associated with the HepII domain reflect the binding specificity at this
position (Figure 3B; horizontal arrows above HepII region), which is highest for CS followed by DS and then
HA and PTS. A higher affinity and/or specificity of binding for CS is also evident in single molecule FNpolymer unbinding forces that are significantly higher for CS (164 ± 10.1 pN, n = 61) compared to DS (115 ±
11.0 pN, n = 41), HA (108 ± 8.5 pN, n = 30) and PTS (124 ± 12.5 pN, n = 66) (Fig. 3C). Along with heparin, CS
is a main competitor in FN binding with important binding determinants located to the HepII FNIII13-14
domains39. Heparin-FN interactions have been mimicked using synthetic polysaccharides like DS 40, while
for the non-sulfated HA it is uncertain if binding on its own is possible or requires the presence of
mediating proteoglycans 41. Many of these early studies involve binding of FN fragments whereas our
approach using intact FN shows that all polymers, including those with HA, are capable of specific binding.
Even for small molecular weight PTS bearing a single sulfate group per molecule, its distribution at the
polymer surface is sufficient to enable specific binding of the HepII domain.

Effect of Electrical Stimulation on Fibronectin Binding
In contrast to measurements on gold electrodes that show no adhesion dependence on the applied
potential (Figure 4A), FN adhesion on the polymers significantly increases by ≈ 5 – 10 times at positive
potentials and then decreases as the applied potential is reversed (Figure 4B). This is highlighted in force
profiles of the gold electrode (Figure 4A) and CS doped polymer (Figure 4B) acquired at applied potentials
of +0.4 V, 0 V and -0.4 V during the cyclic voltammograms. The reversibility of adhesion during cycling of
the potential between +0.4 V and -0.4 V is conveyed in graphs that are analogous to cyclic voltammograms
(solid grey curve) but plot the maximum adhesion force (black dashed curve) as a function of voltage
(Figure 5). Combining force and cyclic voltammetry measurements has recently been demonstrated for
DNA interactions on gold electrodes and referred to as ‘Roburograms’ (Robur is the Latin for ‘force’) 42. All
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the polymers showed a similar response, in particular, a dramatic reversible adhesion between 0.2-0.4 V at
scan rates of 50 mV/sec. Although the interaction of multiple FN molecules is likely, the increase in
adhesion does not scale with (n) possible number of interacting proteins given that a single compact FN
molecule of ≈ 20 * 15 nm is comparable to the interaction area of the probe. Compared to the gold, the
polymer electrode micro- and nanotopography and porosity significantly increase the charge storage
capacity, as evidenced by a significant increase in the area of the cyclic voltammograms (Figure 5, c.f. gold
and polymer). A related increase in surface charge density is most likely responsible for a strong columbic
attraction with the majority of negatively charged FN domains that effectively “pins-down” the protein.
Furthermore, the outward diffusion of charge balancing cations occupying anionic sites on the dopant
during the applied potential is rate limiting. This renders the anionic sites unavailable for neutralization of
positive charges generated on the polymer backbone – thus giving rise to a high positive surface charge
density. When cycling at slower scan rates of 5mV/sec, as demonstrated for CS doped polymers, the ion
diffusion is conversely not rate-limited and charge neutralization of the polymer can proceed to negate
attraction of the FN (Figure 5).

Molecular Switching of Fibronectin Binding & Conformation via Electrochemical Control
Based on the above picture emerging of the FN interactions, we propose a model that provides molecular
insight into the switching mechanisms of single molecule FN-conducting polymer interactions, particularly
as the protein alters binding affinity and conformation in response to equilibrium and non-equilibrium
redox states of the polymer under electrical control (Figure 6). The involvement of heparin domains in
binding to the non-electrically stimulated polymers is explained by a ‘bio-specific’ interaction whereby
cationic sites of the protein and anionic sites of the dopant undergo charge polarization at small separation
distances (Figure 6A). The implication for the subsequent formation of discrete bonds at heparin domains,
coupled to the flexibility of the protein’s extended conformation, is that local structural changes are
induced to actively present cell binding (RGD) domains 43. This binding configuration can be
electrochemically switched to induce non-specific binding (Figure 6B); a reversible process that is expected
to significantly alter the protein conformation. Oxidation of the polymer results in a dramatic increase in
binding strength; however the flexibility of the protein is diminished (Figure 6B). During reduction of the
polymer, the polymer backbone is uncharged and the protein is presumably able to interact with free
anionic groups in a similar manner to the non-stimulated polymer (Figure 6C). While others have focused
on the FN conformation18, 19, 20, our study uniquely quantifies the FN-polymer interfacial forces that play a
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critical role in force-dependent signal transduction processes such as cellular forces exerted on FN through
integrins to regulate cell adhesion and migration.
Conclusions
The study demonstrates a new approach by using AFM to directly measure biomolecular recognition of
single molecules under electrical control that is also valuable in its application to other organic conductors
(e.g. graphene and carbon nanotubes), semiconductors and metals. The approach will be of significant
interest in the areas of the cell-electromaterial interface, organic bioelectronics, electrophysiology and
implantable electrodes (e.g. cochlear implant), particularly as researchers endeavour to fabricate organic
electrodes that make better electrical ‘connections’ to living cells and tissues. It opens up the possibility of
assessing a range of other biomolecules (e.g. growth factors) whose redox-controlled surface binding and
subsequent release is implicated as an important strategy for temporally controlling nerve, muscle and
stem cell growth and survival. It is also likely to burgeon in the immense field of electrically-based
biosensing that is heavily reliant upon biomolecular recognition at electrodes.

Acknowledgements: This work has been supported by the Australian Research Council under the
Australian Research Fellowship and DP110104359 (Dr Michael Higgins) and ARC Federation Fellowship of
Prof. Gordon Wallace. We also greatly acknowledge the Australian National Fabrication Facility (ANFF) for
providing Atomic Force Microscopy instrumentation.

Page 10 of 21

Methods:
The pyrrole monomer was obtained from Merck and distilled prior to use. The chemicals used as the
dopants were the sodium salts of para-toluenesulfonic acid (pTS), hyaluronic acid (HA), dextran sulfate (DS)
and chondroitin sulfate A (CS). CS and DS were obtained from Sigma, pTS from Merck and HA from Fluka.
All solutions were prepared with deionised Milli-Q water (18.2MΩ). Gold coated mylar was firstly prepared
by cutting into strips of 0.5 cm by 2 cm area and then cleaned with methanol and Milli-Q water. An
aqueous monomer solution of 0.2 M pyrrole and 2 mg/mL of the counter-ion dopant was degassed in N2
for 10 min prior to polymerisation of the polymers. Polypyrrole (PPy) films were grown galvanostatically at
a current density of 0.25 mA/cm2 for 10 min in the aqueous monomer solution using an eDAQ EA161
potentiostat and recorder to monitor the polymerization charge. Polymer growth was performed in a
standard 3-electrode electrochemical cell with the gold coated mylar as the working electrode, a platinum
mesh counter electrode and Ag/AgCl reference electrode. After growth, the films were washed with Milli-Q
water, gently dried with N2 gas and placed in petri dishes until use.
The functionalization chemicals 3-ethoxydimethylsilylamine propyl (3-EDSPA) and gluteraldehyde
(GAH) were obtained from Sigma Aldrich. Human plasma fibronectin (FN) was obtained from Sigma
Aldrich. Phosphate buffer saline (PBS) was prepared at pH 7 in Milli-Q water (18.2MΩ). The tip is
functionalized using an aminosilzation method to covalently bind the protein to the tip. Silicon nitride tips
are used for this method due to the availability of silicon oxide groups on the surface. The tips were initially
cleaned with a plasma cleaner to remove any impurities or functionalized groups on the surface. Once
cleaned the tips were immediately functionalized to minimise contaminants on the surface. The tips were
placed into the EDSPA solution at room temperature for 1 h. The tips were then removed, washed
consecutively with toluene, then PBS solution. The tips were then immersed in the GAH solution for 1 h,
and then rinsed with PBS solution. The tips were finally immersed in the FN solution for 1 h, then rinsed
and refrigerated in PBS solution until use. To visualize functionalization of the tips, FN functionalized AFM
probes were prepared for antibody binding using Alexa488 goat anti-rabbit IgG (Invitrogen) and primary
anti-fibronectin rabbit antibody (ICN Biomedicals Inc). The tips were blocked in PBS with 10% donkey
serum at room temperature for 1 hr then incubated in primary anti-fibronectin (rabbit) antibody in PBS
with 10% donkey serum at 37 °C. The tips were rinsed twice in PBS, then incubated in a secondary antibody
(Alexa488 goat anti-rabbit IgG) in PBS with 10% donkey serum. The tips were then rinsed twice with PBS
and imaging using the Zeiss Axio Epifluorence microscope.
Electrochemical–AFM (EC-AFM) was implemented by positioning a 2-dimensional electrochemical
cell on the sample stage of an MFP-3D Asylum Research AFM (Santa Barbara, CA). The electrochemical cell
was made out of a Teflon block that consisted of a u-shaped fluid well etched around a platform. A PPy
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polymer film was glued onto the platform and acted as the working electrode. A platinum mesh counter
electrode was positioned in the fluid well and a silver wire pseudo-reference electrode was placed
alongside the polymer film. Electrochemical measurements were controlled using an eDAQ EA161
potentiostat/recorder and carried out in PBS buffer solution, which was injected into the fluid well to
immerse the three electrodes. Force spectroscopy measurements were firstly performed on nonelectrically stimulated films with PBS as the electrolyte. 5 consecutive force curves were collected at one xy position with a total of 5 different positions across the film being sampled. This was repeated using 3
different functionalized tips on the same film. For each of the differently doped films (i.e. CS, DS, HA, PTS),
a total of 3 film samples were measured. Force curve parameters included a 500 nm ramp distance, 0.5 Hz
scan rate, 1 sec dwell time at the surface and trigger force of 1nN. Force curves were then acquired during
electrical stimulation of the films under the EC-AFM. Polymer films were electrically stimulated by applying
cyclic voltammetry from -400 to +400 mV with either scan rates of 50mV/sec or 5mV/sec for 5 cycles. The
z-piezo and deflection signal were outputted to the eDAQ EA161 potentiostat/recorder and recorded
simultaneously with the current and voltage. Analysis of the force curves were carried out using the
Asylum AFM software in IGOR PRO (Wavemetrics)
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Figure Legends:

Figure 1. A) Schematic of procedure for protein functionalization of AFM tip. B) Fluorescence image of
fluorescently labelled AFM tip before (left image) and after (right image) protein functionalization. C) AFM
force curves performed on PPy/CS after each functionalization step, including plasma treatment (SiN3),
amino-salinization (3-EDSPA), gluteraldehyde treatment (GAH) and final coupling of the protein (FN).
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Figure 2. A) Schematic diagram of AFM tip functionalized with FN interacting with a conducting polymer
electrode (blue), polypyrrole (PPy), comprising a conjugated backbone (black chemical structure) with
entrapped dopants (green) such as chondroitin sulphate (CS), hyaluronic acid (HA) or dextran sulfate (DS).
FN is a protein dimer comprising two identical monomers linker by a pair of C-terminal disulfide bonds.
Each monomer contains three types of repeating domains, types FNI (orange rectangle), FNII (blue
diamond), FNIII (red ovals) and an N-terminal. Force spectroscopy measurements were performed as a
function of an applied voltage using electrochemical–AFM. The PPy-electrode operated as the working
electrode in 3-electrode electrochemical cell, including auxiliary and reference electrodes, positioned
under the AFM. B) AFM force curves for the interaction of FN with non-electrically stimulated PPy/CS
showing the trace (orange) and retrace (blue) curves. The peak at (i) corresponds to initial detachment of
the tip and fibronectin molecules from the surface. The two subsequent peaks (1st and 2nd dashed lines)
and their spacing of 27.1 nm (ii) and 28.5 nm (iii) correspond to the sequential unfolding of FNIII modules
(~ 75 amino acid residues). A peak spacing of 47.8 nm at point (iv) is greater than that for FN unfolding and
correlates with multiple detachment of FN-polymer binding sites. The first binding site detaches (3rd
dashed line) followed by extension of the protein until the second and final site detaches (4th dashed line).
Such binding events can occur in the absence of domain unfolding (point v in bottom curve).

C)

Corresponding schematic depicting the different interactions in top curve in (A). (i) non-specific adhesion
peak; (ii) unfolding of 1st domain (red circle); (iii) unfolding of 2nd domain (red circle); (iv) detachment of 1st
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FN-polymer binding site (green triangle); (final peak) detachment of 2nd and final FN-polymer binding site
(green triangle). For analysis of the corrected binding distance (CBD), the “added” distances gained during
extension of the protein (i.e. peak spacings due to unfolding/multiple detachment sites) are subtracted
from the final peak distance. The CBD (vertical arrow) therefore represents the extended length of the FN
prior to unfolding or surface detachment and is effectively the same situation as that depicted prior to (ii).
D) Probability density functions of distances between successive rupture peaks in force profiles from all
polymers. Red curves are individual gaussian fits and automated multipeak fitting (blue curves) (IGOR PRO,
Wavemetrics). Peak distributions at 13.1 ± 0.4 nm (mean ± s.e.m., n = 137) and 28.8 ± 0.7 nm (mean ±
s.e.m., n = 107) have previously been attributed to intermediate and fully unfolded lengths of FNIII
domains, respectively. Higher peak value distributions at 58.9 ± 3.0 nm (mean ± s.e.m., n = 67) correspond
to distances between multiple protein-polymer binding sites.

Figure 3. A) Probability density functions of corrected binding distance (CBD) for CS (n = 121), DS (n = 77),
HA (n = 65), PTS (n = 112) doped polymers. Light grey curves are individual gaussian fits and automated
multipeak fitting (solid dark curves) (IGOR PRO, Wavemetrics). The peak CBD distribution values labelled in
blue are: (CS) 59.0 ± 9.3 nm (mean ± s.d., n = 70), 116.0 ± 11.7 nm (mean ± s.d., n = 27), 171.0 ± 6.6 nm
(mean ± s.d., n = 13); (DS) 64.3 ± 13.6 nm (mean ± s.d., n = 51), 116.7 ± 3.8 nm (mean ± s.d., n = 16); (HA)
65.5 ± 18.0 nm (mean ± s.d., n = 38), 119.1 ± 6.3 nm (mean ± s.d., n = 20); (PTS) 59.9 ± 14.4 nm (mean ±
s.d., n = 69), 116.0 ± 8.5 nm (mean ± s.d., n = 22), 166.0 ± 8.6 nm (mean ± s.d., n = 14). B) Model of
extended FN showing calculated length of 158.8 nm based on x-ray crystallography dimension of FNI (2.5
nm, rectangles), FNII (0.7 nm, diamonds) and FNIII (3.2 nm, ovals), where 0 nm corresponds to the
attachment position of FN to the AFM tip. The heparin binding domains, HepIIFN12-14 (position = 59.1 – 68.7
nm), HepIIIFN4-6 (position = 115.7– 125.3 nm) and HepIFN1-5 (position = 143.2– 158.8 nm) are coloured in
black. The peak CBD distribution values labelled in (A) and listed above are marked at their respective
positions on the protein with a black asterix. Standard deviations calculated from the full width half
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maximum (FWHM) (where FWHM = 2 √2ln2σ) of peak CBD distribution values of the HepIIFN12-14 domain
for each dopant are given by the length of the horizontal arrows. C) Single molecule FN-polymer unbinding
forces for each polymer. The values are taken from the force value of the final peak (detachment of the
polymer) and represent the primary peak distribution of probability density functions.

Figure 4. Representative force curves for (A) gold electrode and (B) PPY/CS polymer taken at 400 mV, 0
mV and -400 mV from a cyclic voltammogram with a scan rate of 50mV/sec.
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Figure 5. Maximum adhesion force (black dashed curve) versus voltage and corresponding cyclic
voltammograms (solid grey curve) for the gold electrode and PPy polymer films doped with CS, DS, HA and
pTS. The adhesion force values (black circles) represent an average from individual force curves collected
at each time point during 3 CV cycles performed at a scan rate of 50mV/sec. The bottom right graph is the
same measurement performed for the PPy/CS CS polymer at a slower scan rate of 5 mV/sec.
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Figure 6. A) Non-Electrically Stimulated Polymer: The model translates the AFM observations to the
expected binding interaction of a single FN molecule (only one FN monomer is shown) given the
involvement of multiple heparin domains (blue domains). The ability of multiple binding via the different
heparin domains indicates that the FN is more likely to adopt an extended conformation, which is depicted
in the model based on previous representations of unfolded FN adsorbed onto negatively charged
surfaces44. This configuration is considered to be more bioactive due to the presentation of RGD regions.
Because FN is an amphoteric protein, repulsion of the predominately negatively charged protein with
sulfate or carboxyl groups (green charges) of the GAGs can revert to attractive forces due to preferential
alignment of the cationic heparin domains (blue highlighted). When the protein is at a very small
separation distance from the polymer, the charges interact as discrete entities rather than part of an
overall net charge and subsequent columbic attraction of individual ion pairs governs the protein-surface
binding, as opposed to the net protein interaction. This type of bio-specific interaction is referred to as
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“charge complementarity” 45. B) Electrically Stimulated Polymer: The application of a positive voltage
induces charge (black positive charge) on the polymer backbone causes a strong columbic attraction of the
negatively charged FN domains. At higher scan rates (50 mV/sec), outward diffusion of charge balancing
cations (C+) occupying anionic sites on the immobile GAGs is rate limiting. This renders anionic sites on the
dopant unavailable for charge neutralization of the positive charges on the polymer and protein adhesion
is present. At lower scan rates (5mV/sec), outward cation diffusion (black arrows) is not rate-limited and
charge neutralization of the polymer proceeds to decrease protein adhesion. C) During the application of
negative potentials, the polymer backbone is uncharged and free sulfate or carboxyl groups are expected
to similarly interact with the protein, as described above in (A). The mechanism is reversible (red arrow)
between (B) and (C).
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